Beginning July 1, 2026, Centers for Medicare & Medicaid Services (CMS) will operate the Medicare GLP-1 Bridge, a short-term demonstration intended to provide eligible Medicare Part D beneficiaries with access to certain GLP-1 medications for weight management
Thats the protein in your red blood cells that helps carry oxygen throughout your body
Semaglutide remains partially active during the first few days of the washout period
A relaxed introduction where we review IV therapy options, answer questions, and guide you toward the right wellness choice
Wanko, GLP-1 medication is a good weight-loss option for patients who: Have a BMI over 30 Have a BMI over 27 with at least one weight-related health problem like diabetes, high blood pressure or high cholesterol Need additional help to increase or maintain weight loss after bariatric surgery To improve your health, a GLP-1 must be part of a more comprehensive approach